← Back to Search

Dialogue-Based Webinar for COVID-19

N/A
Waitlist Available
Led By Glyn Elwyn
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
at least somewhat worried about the COVID-19 vaccines and/or has not received a COVID-19 vaccine booster shot
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (time 0); 3 weeks post-randomization (time 1); 3 months post-randomization (time 2); 6 months post-randomization (time 3)
Awards & highlights

Study Summary

This trial will help long-term care workers in the United States feel more confident about the Coronavirus Disease 2019 (COVID-19) vaccines by comparing two different interventions to usual online information.

Eligible Conditions
  • COVID-19
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are concerned about the COVID-19 vaccines or have not received a booster shot for COVID-19.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (time 0); 3 weeks post-randomization (time 1); 3 months post-randomization (time 2); 6 months post-randomization (time 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (time 0); 3 weeks post-randomization (time 1); 3 months post-randomization (time 2); 6 months post-randomization (time 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
COVID-19 vaccine confidence
Secondary outcome measures
As-treated analyses of primary
COVID-19 vaccine intent (booster)
COVID-19 vaccine intent (future vaccine recommendations)
+11 more
Other outcome measures
Dialogue-Based Webinar acceptability
Dialogue-Based Webinar exposure
Enhanced Usual Practice acceptability
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Social Media WebsiteExperimental Treatment1 Intervention
Group II: Dialogue-Based WebinarExperimental Treatment1 Intervention
Group III: Enhanced Usual PracticeActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dialogue-Based Webinar
2022
N/A
~2640
Social Media Website
2022
N/A
~2640

Find a Location

Who is running the clinical trial?

East Carolina UniversityOTHER
106 Previous Clinical Trials
36,108 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
548 Previous Clinical Trials
29,993,952 Total Patients Enrolled
10 Trials studying COVID-19
461,580 Patients Enrolled for COVID-19
National Association of Health Care AssistantsUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available spots to join this investigation?

"Affirmative. Clinicaltrials.gov confirms that this clinical experiment, which was uploaded on February 21st 2022, is actively searching for participants. The researchers need to enroll 1800 patients from a single location."

Answered by AI

What is the recruitment capacity of this research project?

"Affirmative. Clinicaltrials.gov provides information which attests to the active recruitment for this medical trial, first posted on February 21st 2022 and most recently updated October 13th 2022. 1800 patients are being sought from one designated facility."

Answered by AI
Recent research and studies
~854 spots leftby Mar 2025